3csf
From Proteopedia
(Difference between revisions)
m (Protected "3csf" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
[[Image:3csf.png|left|200px]] | [[Image:3csf.png|left|200px]] | ||
- | <!-- | ||
- | The line below this paragraph, containing "STRUCTURE_3csf", creates the "Structure Box" on the page. | ||
- | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
- | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
- | or leave the SCENE parameter empty for the default display. | ||
- | --> | ||
{{STRUCTURE_3csf| PDB=3csf | SCENE= }} | {{STRUCTURE_3csf| PDB=3csf | SCENE= }} | ||
===Crystal structure of PI3K p110gamma catalytical domain in complex with organoruthenium inhibitor DW2=== | ===Crystal structure of PI3K p110gamma catalytical domain in complex with organoruthenium inhibitor DW2=== | ||
- | |||
- | <!-- | ||
- | The line below this paragraph, {{ABSTRACT_PUBMED_18484710}}, adds the Publication Abstract to the page | ||
- | (as it appears on PubMed at http://www.pubmed.gov), where 18484710 is the PubMed ID number. | ||
- | --> | ||
{{ABSTRACT_PUBMED_18484710}} | {{ABSTRACT_PUBMED_18484710}} | ||
Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
- | *[[Phosphoinositide 3-Kinases]] | + | *[[Phosphoinositide 3-Kinases|Phosphoinositide 3-Kinases]] |
==Reference== | ==Reference== | ||
- | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:018484710</ref><references group="xtra"/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase]] | [[Category: Phosphatidylinositol-4,5-bisphosphate 3-kinase]] |
Revision as of 09:38, 26 July 2012
Contents |
Crystal structure of PI3K p110gamma catalytical domain in complex with organoruthenium inhibitor DW2
Template:ABSTRACT PUBMED 18484710
About this Structure
3csf is a 1 chain structure of Phosphoinositide 3-Kinases with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Xie P, Williams DS, Atilla-Gokcumen GE, Milk L, Xiao M, Smalley KS, Herlyn M, Meggers E, Marmorstein R. Structure-based design of an organoruthenium phosphatidyl-inositol-3-kinase inhibitor reveals a switch governing lipid kinase potency and selectivity. ACS Chem Biol. 2008 May 16;3(5):305-16. PMID:18484710 doi:http://dx.doi.org/10.1021/cb800039y